© 2007 European Society for Medical Oncology
editorial |
National integration of European standards
1 Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
2 Karolinska Hospital, Stockholm, Sweden
* (E-mail: bajetta@istitutotumori.mi.it)
| The first 10% of the full text of this article appears below. |
Over the last 20 years, increasing life expectancy has become a major determinant of increasing cancer incidence, and the World Health Organization has estimated that with this ageing of populations there could, by 2020, be 16 million new cases per year and
10 million deaths. In Europe, where primary prevention, screening and application of modern cancer therapies have led in recent years to generally decreasing trends in age-standardized mortality rates, it has nevertheless been estimated that there will be
1.25 million cancer deaths
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
On behalf of ESMO and J. Baselga Creating a stronger front against cancer: ESMO and ECCO join forces Ann. Onc., August 1, 2008; 19(8): 1367 - 1368. [Full Text] [PDF] |
||||
